Madden Martin J.

Madden Martin J. is listed in filings as Director at NovoCure Ltd. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to NovoCure Ltd (NVCR) and Microbot Medical Inc. (MBOT). The current snapshot covers public activity from Jan 30, 2025 to Jun 5, 2026. Reported amounts are shown as $274.5K to $558.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.